Jan 15 (Reuters) - Benitec Biopharma Ltd BLT.AX :
* U.S. FDA HAS GRANTED ORPHAN DRUG DESIGNATION TO BB-301 FOR TREATMENT OF OCULOPHARYNGEAL MUSCULAR DYSTROPHY(OPMD)
Jan 15 (Reuters) - Benitec Biopharma Ltd BLT.AX :
* U.S. FDA HAS GRANTED ORPHAN DRUG DESIGNATION TO BB-301 FOR TREATMENT OF OCULOPHARYNGEAL MUSCULAR DYSTROPHY(OPMD)